INDIA (1935)

PHARMACEUTICALS

Cipla is born
y In 1 35,DR. Khwaja Abdul Hamied set up The

Chemical, Industrial & Pharmaceutical Laboratories, which came to be popularly known as Cipla.
y On August 17, 1 35, Cipla was registered as a public

limited company with an authorised capital of Rs 6 lakhs. y The office was set up at at 289, Bellasis Road Mumbai (the present corporate office)

y 1941 y As the Second World War cuts off drug supplies, the

company starts producing fine chemicals, dedicating all its facilities for the war effort.(Vikhroli)
y 1952 y Sets up first research division for attaining self-sufficiency

in technological development.
y y 1960 y Starts operations at second plant at Vikhroli, Mumbai,

producing fine chemicals with special emphasis on natural products.

y

y y y y y

1968 Cipla manufactures ampicillin for the first time in the country. 1972 Starts Agricultural Research Division at Bangalore, for scientific cultivation of medicinal plants.

y y 1976 y Cipla launches medicinal aerosols for asthma. y 1980 y Wins Chemexcil Award for Excellence for exports. y 1982 y Fourth factory begins operations at Patalganga, Maharashtra.

y 1988 y Cipla wins National Award for Successful Commercialisation

of Publicly Funded R&D.

y 1991 y Lauches etoposide, a breakthrough in cancer chemotherapy,

in association with Indian Institute of Chemical Technology.

y 1994 y Cipla's fifth factory begins commercial production at

Kurkumbh, Maharashtra.
y.

y 1997 y Launches transparent Rotahaler, the world's first such dry

powder inhaler device now patented by Cipla in India and abroad. The palliative cancer care centre set up by the Cipla Foundation, begins offering free services at Warje, near Pune
y 1999 y Launches Nevirapine, antiretroviral drug, used to prevent the

transmission of AIDS from mother to child.

y 2000 y Cipla became the first company, outside the USA and Europe

to launch CFC-free inhalers ten years before the deadline to phase out use of CFC in medicinal products.

y 2005 y Set-up state-of-the-art facility for manufacture of

formulations at Baddi, Himachal Pradesh.

y y 2007 y Set-up state-of-the-art facility for manufacture of

formulations at Sikkim.
y y 2010 y Set up state-of-the-art facility for manufacture of

formulations at Indore.

GLOBAL OPERATION
y OVER 180 countries around the globe

Areas of Strength
Make and sell products of highest quality Dominant market share position Low-cost, high operating skill Effectiveness in sales promotion Quality sales force

KEY PEOPLE
Founder Dr. K.A. amied (1898-1972)

Dr. Y.K.

amied

JOINT MANAGING DIRECTORS

M r. M . K . a m i e d M r. A m a r L u l l a

NON-EX ECUTIVE D IRECTORS

M r. V. C . Ko t wa l D r. . R . Ma n c h a n d a M r. . A . A . i n to M r. M . R . R a gh ava n M r. R a m e s h h ro f f M r. a n k a j a te l

AT PRESENT
 Exports for the financial year ended March 31, 2011

amounted to more than Rs. 29,000 million.  Cipla exports raw materials, intermediates, prescription drugs, OTC products and veterinary products. Cipla also offers technology for products and processes.
 Technical know-how/fees received during the year

2010-11 amounted to about Rs. 1500 million.

Cipla's manufacturing facilities have been approved by various international regulatory authorities including:
y Food and Drug Administration (FDA), USA y Medicines and Healthcare products Regulatory

Agency (MHRA), UK
y Therapeutic Goods Administration (TGA), Australia y Medicines Control Council (MCC), South Africa

y National Institute of Pharmacy (NIP), Hungary y Pharamaceutical Inspection Convention (PIC),

Germany
y World Health Organisation (WHO) Department of

Health, Canada
y State Institute for the Control of Drugs, Slovak

Republic ANVISA, Brazil

Foracort Autohaler contains 6 mcg of formoterol and 200 mcg of budesonide. This combination is an effective and convenient option for the maintenance treatment of patients with asthma

Levolin (levosalbutamol) Autohaler is the world's first - easy to use, breath actuated inhaler (BAI).

ZOLMIST , ic is a e a iti t t e list f Indi 's first br nds by Ci l , tar ets t ffer ic c siste t e efits i i rai e atie ts el i rai e atie ts t head towards relief in minutes .

PRODUCTS
Animal ealth Care roducts
Aqua Products Disinfectants and Sanitizers Equine Products Feed and Feed Additives General Products Herbal Products Pluto s Choice Dog Treats &Chews Poultry Products Surgical and Equipments Acti e harmaceutical In redients

Arthritic / Rheumatic Agents Antibiotics / Antibacterials Anticancer Drugs Anti-emetics Antifungals Antihelmintics Antihistamines Antimalarials y

Flavours & Fragrances

Flavours
y BeveragesBiscuits & y BakeryConfectionary & Gum y Based ProductsDairy y Products & Frozen y DessertsDistilled Alcoholic y BeveragesDust On & Powder y FlavourFruit Juice & Other y Fruit Based y BeveragesPharmaceuticals

Fragrances
y Agarbathi -Incense

SticksCosmeticsDetergents y LaundryFine FragranceHair y Oil, Gel & LotionsLiquid y SoapsTalcum Powder

Agrochemicals

echnology ervices
y Consulting

Fungicide Herbicide Insecticide Organic Products Plant Growth RegulatorProducts

y y y y y y y y

roject appraisal Engineering lant supply Commissioning raining Operational management upport Quality control

y Quality Chemicals Industries Ltd., a Ugandan

pharmaceuticals manufacturer partly owned by India s Cipla Ltd., said it plans to invest $80 million in two separate expansion programs over the next two years.

y A $30 million project to expand capacity at Quality s

generic AIDS and malaria-drug plants in Kampala, the capital, will begin soon, Marketing Manager George Baguma said in a phone interview on Jan. 28. It will be followed by a $50 million investment in a new production line for pharmaceutical ingredients,

MAJOR COMPETITORS